ArticleArchives of virology2026
Superinfection Exclusion Between Japanese Encephalitis Virus Genotypes I and III Occurs During Viral Entry.
Article in Archives of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Superinfection exclusion occurs when a primary viral infection prevents subsequent infection of the same cell. Japanese encephalitis virus (JEV) comprises several genotypes that differ primarily in their envelope protein sequences, and a shift in predominance from genotype III (GIII) to genotype I (GI) has been observed in nature. However, the mechanisms contributing to this genotype replacement remain unclear. In this study, we examined superinfection exclusion between JEV GI and GIII in mammalian BHK-21 cells and mosquito C6/36 cells. Reciprocal exclusion was observed in both cell types. Further analysis in BHK-21 cells, using GIII as the primary virus and GI as the secondary virus, indicated that inhibition occurred at the viral entry stage. The extent of exclusion increased as the interval between primary GIII infection and secondary GI infection was prolonged, indicating that superinfection exclusion became progressively stronger over time. Quantitative analysis using fluorescently labeled GI virus and RT-qPCR further showed that GI entry was significantly reduced in cells previously infected with GIII compared with mock-infected controls. Transferrin uptake remained readily detectable in JEV-infected cells, suggesting that prior infection did not grossly impair transferrin internalization under the conditions examined. Together, these findings demonstrate superinfection exclusion between JEV GI and GIII and indicate that interference occurs predominantly during viral entry. The potential contribution of this phenomenon to JEV genotype replacement in nature warrants further investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.